Ameritas Advisory Services LLC Boosts Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Ameritas Advisory Services LLC boosted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 9.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 29,094 shares of the financial services provider’s stock after acquiring an additional 2,508 shares during the quarter. Ameritas Advisory Services LLC’s holdings in iShares Biotechnology ETF were worth $3,847,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. BNP Paribas Financial Markets increased its position in iShares Biotechnology ETF by 29.3% during the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after acquiring an additional 538,899 shares during the last quarter. Commerce Bank increased its position in iShares Biotechnology ETF by 1.8% during the third quarter. Commerce Bank now owns 743,366 shares of the financial services provider’s stock valued at $108,234,000 after acquiring an additional 12,921 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its position in iShares Biotechnology ETF by 32.9% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after acquiring an additional 164,000 shares during the last quarter. Main Management ETF Advisors LLC increased its position in iShares Biotechnology ETF by 2.5% during the third quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock valued at $86,395,000 after acquiring an additional 14,535 shares during the last quarter. Finally, Aprio Wealth Management LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter valued at about $18,476,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

NASDAQ:IBB opened at $132.65 on Monday. The stock has a 50-day simple moving average of $136.62 and a two-hundred day simple moving average of $141.86. iShares Biotechnology ETF has a 52-week low of $123.60 and a 52-week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.